BioNexus Gene Lab Corp. (BGLC)
USD 0.26
(-2.99%)
USD 0.26
(-2.99%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.48 Million USD | -1237.85% |
| 2022 | -185.76 Thousand USD | -115.96% |
| 2021 | 1.16 Million USD | -15.37% |
| 2020 | 1.37 Million USD | 718.52% |
| 2019 | -222.37 Thousand USD | -321.24% |
| 2018 | 100.51 Thousand USD | 189.04% |
| 2017 | -104.38 Thousand USD | -13338.1% |
| 2016 | - USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -439.48 Thousand USD | 687.85% |
| 2024 Q1 | -251.29 Thousand USD | -117.26% |
| 2023 Q3 | -2.49 Million USD | -909.0% |
| 2023 FY | - USD | -1237.85% |
| 2023 Q2 | -247.59 Thousand USD | -861.07% |
| 2023 Q1 | -25.76 Thousand USD | 73.34% |
| 2023 Q4 | 286.36 Thousand USD | 111.46% |
| 2022 FY | - USD | -115.96% |
| 2022 Q4 | -96.63 Thousand USD | -145.37% |
| 2022 Q3 | -39.38 Thousand USD | 64.55% |
| 2022 Q2 | -111.08 Thousand USD | -281.1% |
| 2022 Q1 | 61.33 Thousand USD | -73.05% |
| 2021 Q2 | 179.81 Thousand USD | -49.65% |
| 2021 FY | - USD | -15.37% |
| 2021 Q1 | 357.15 Thousand USD | -76.5% |
| 2021 Q4 | 227.57 Thousand USD | -43.03% |
| 2021 Q3 | 399.45 Thousand USD | 122.15% |
| 2020 Q4 | 1.51 Million USD | 3195.92% |
| 2020 Q2 | -53.76 Thousand USD | -58.36% |
| 2020 FY | - USD | 718.52% |
| 2020 Q3 | -49.09 Thousand USD | 8.69% |
| 2020 Q1 | -33.95 Thousand USD | 37.62% |
| 2019 FY | - USD | -321.24% |
| 2019 Q1 | -49.64 Thousand USD | 19.64% |
| 2019 Q4 | -54.42 Thousand USD | -20.72% |
| 2019 Q3 | -45.08 Thousand USD | 23.37% |
| 2019 Q2 | -58.82 Thousand USD | -18.5% |
| 2018 Q1 | -38.59 Thousand USD | 24.2% |
| 2018 FY | - USD | 189.04% |
| 2018 Q4 | -61.77 Thousand USD | -36.75% |
| 2018 Q3 | -45.17 Thousand USD | -54.77% |
| 2018 Q2 | -29.18 Thousand USD | 24.38% |
| 2017 Q4 | -50.92 Thousand USD | 0.0% |
| 2017 FY | - USD | -13338.1% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bionano Genomics, Inc. | -213.6 Million USD | 98.837% |
| Prenetics Global Limited | -47.89 Million USD | 94.811% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -47.312% |
| CareDx, Inc | -89.65 Million USD | 97.228% |
| Exact Sciences Corporation | 41.87 Million USD | 105.935% |
| Exagen Inc. | -19.15 Million USD | 87.025% |
| Inotiv, Inc. | -26.5 Million USD | 90.624% |
| Guardant Health, Inc. | -433.3 Million USD | 99.426% |
| Biodesix, Inc. | -37.1 Million USD | 93.302% |
| Precipio, Inc. | -4.31 Million USD | 42.446% |
| iSpecimen Inc. | -9.1 Million USD | 72.702% |
| Natera, Inc. | -383.27 Million USD | 99.352% |
| Aspira Women's Health Inc. | -16.49 Million USD | 84.93% |
| Standard BioTools Inc. | -54.45 Million USD | 95.436% |
| 23andMe Holding Co. | -291.87 Million USD | 99.149% |
| Castle Biosciences, Inc. | -45.02 Million USD | 94.48% |
| Personalis, Inc. | -96.8 Million USD | 97.433% |
| Aclaris Therapeutics, Inc. | -117.56 Million USD | 97.886% |
| Applied DNA Sciences, Inc. | -9.59 Million USD | 74.089% |
| OpGen, Inc. | -29.51 Million USD | 91.579% |
| T2 Biosystems, Inc. | -43.87 Million USD | 94.336% |
| Myriad Genetics, Inc. | -67.8 Million USD | 96.335% |
| ICON Public Limited Company | 1.63 Billion USD | 100.152% |
| NeoGenomics, Inc. | -17.6 Million USD | 85.885% |
| Star Equity Holdings, Inc. | -1.68 Million USD | -47.312% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | 100.204% |
| RadNet, Inc. | 292.78 Million USD | 100.849% |
| MDxHealth SA | -30.46 Million USD | 91.843% |
| Psychemedics Corporation | -251 Thousand USD | -890.104% |
| Illumina, Inc. | -608 Million USD | 99.591% |
| Check-Cap Ltd. | -17.64 Million USD | 85.919% |
| Twist Bioscience Corporation | -176.7 Million USD | 98.594% |
| DarioHealth Corp. | -53.49 Million USD | 95.354% |
| Fulgent Genetics, Inc. | -46.55 Million USD | 94.662% |
| Sera Prognostics, Inc. | -35.28 Million USD | 92.957% |
| ENDRA Life Sciences Inc. | -9.78 Million USD | 74.602% |
| OPKO Health, Inc. | -65.51 Million USD | 96.207% |
| Medpace Holdings, Inc. | 363.15 Million USD | 100.684% |
| Neogen Corporation | 182.59 Million USD | 101.361% |
| Intelligent Bio Solutions Inc. | -8.81 Million USD | 71.794% |
| Prenetics Global Limited | -47.89 Million USD | 94.811% |
| Mainz Biomed B.V. | -25.01 Million USD | 90.064% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | 67.426% |
| Trinity Biotech plc | -24.09 Million USD | 89.687% |
| Neuronetics, Inc. | -22.75 Million USD | 89.081% |
| Sotera Health Company | 514.14 Million USD | 100.483% |
| bioAffinity Technologies, Inc. | -7.62 Million USD | 67.426% |